About
Neural Omega
We're building the infrastructure that autoimmune research & care have been missing. Where data flows freely, insights emerge faster, and breakthroughs become reality.
Meet the team
Pedro Bernardo Martín-Borregón
Founder & Chief Executive Officer
Medical graduate leading product and technology development. Combines clinical expertise in autoimmune pathology with technical execution, translating frontline patient challenges into scalable digital health solutions.
Bianca Florea Dragoescu
Partners & Strategy
Operations strategist driving Neural Omega's global expansion. Manages partnerships, regulatory frameworks, and growth initiatives, ensuring the ecosystem scales efficiently while maintaining compliance across markets.
What drives us
Clinical Meets Code
We're clinicians who code and engineers who understand immunology. Every algorithm is grounded and tested against real clinical outcomes.
Built With, Not For
Autoimmune patients aren't our users, they're our co-creators. From symptom tracking to AI training, every decision is validated by those who live this daily.
Generational Thinking
We're building for the next 50 years. We optimize for durable scientific infrastructure, data that compounds and models that improve over generations.
The problem we
couldn't ignore
Neural Omega started with a simple observation: autoimmune diseases affect millions of people worldwide, yet the data that could transform their care remains fragmented across disconnected systems.
Patients track symptoms in isolation. Researchers analyze data without real-world context. Clinicians make decisions based on incomplete information. Drug development cycles stretch for years because the feedback loops are broken.
We founded Neural Omega because we believe there's a better way—one that connects these isolated pieces into a unified ecosystem where insights flow freely and breakthroughs happen faster.
People Affected
Autoimmune diseases affect over 500 million people worldwide, yet most face years of trial-and-error treatment.
Years to Market
Average drug development timeline, slowed by fragmented data and lack of real-world evidence integration.
Two platforms, one ecosystem
We've built specialized tools that share a common foundation—creating a continuous feedback loop between care and discovery.
Join us in reshaping autoimmune care
Whether you're a patient, clinician, researcher, or partner—there's a place for you in the Neural Omega ecosystem.